Merck & Co. Inc.
- Market
How well is the COVID-19 test-to-treat program working?
The Biden administration’s test-to-treat program, which allows people who test positive for COVID-19 to leave the pharmacy with a prescription…
Read More » - Market
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week, the latest sign of how dominant it has become
The omicron variant of the coronavirus that causes COVID-19 accounted for 99.8% of global new cases in the latest week,…
Read More » - Market
This development may fully reopen the global economy — and the stock market has mostly ignored it
The buzz surrounding the potential for the antiviral drug from Merck & Co. MRK, -0.43% and Ridgeback Biotherapeutics is hot…
Read More »